Works matching IS 11732563 AND DT 2024 AND VI 44 AND IP 4
1
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 289, doi. 10.1007/s40261-024-01350-6
- Carraro, Gianni;
- Di Vico, Valentina;
- Martinetti, Loris;
- Bettin, Elisabetta;
- Cacciapuoti, Martina;
- Stefanelli, Lucia Federica;
- Gobbi, Laura;
- Nalesso, Federico;
- Martino, Francesca Katiana;
- Calò, Lorenzo A.
- Article
2
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 261, doi. 10.1007/s40261-024-01352-4
- Hagino, Teppei;
- Hamada, Risa;
- Yoshida, Mai;
- Saeki, Hidehisa;
- Fujimoto, Eita;
- Kanda, Naoko
- Article
3
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 223, doi. 10.1007/s40261-024-01351-5
- Kaur, Upinder;
- Pathak, Bhairav Kumar;
- Meerashahib, Tharik Jalal;
- Krishna, Dondapati Venkata Vamshi;
- Chakrabarti, Sankha Shubhra
- Article
4
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 251, doi. 10.1007/s40261-024-01347-1
- Walling, David P.;
- Shinde, Sunita N.;
- Pogoda, Janice M.;
- Kharidia, Jahnavi;
- Laffont, Celine M.
- Article
5
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 271, doi. 10.1007/s40261-024-01354-2
- Tan, Xi;
- Divino, Victoria;
- Amamoo, James;
- Xie, Lin;
- Coyle, Katharine B.;
- Gamble, Cory L.;
- Guevarra, Mico;
- Paprocki, Yurek;
- King, Aaron A.
- Article
6
- Clinical Drug Investigation, 2024, v. 44, n. 4, p. 285, doi. 10.1007/s40261-024-01353-3
- Chaparro, María;
- Ceballos, Daniel;
- Vicente, Raquel;
- Gisbert, Javier P.
- Article